File complaint about threats: Maharashtra govt to SII CEO Poonawalla

A Maharashtra minister on Monday said Serum Institute of India's CEO Adar Poonawalla should lodge a police complaint in connection with the alleged threats that he has received

Adar Poonawalla, CEO, Serum Institute
Adar Poonawalla, CEO, Serum Institute of India
Press Trust of India Mumbai
2 min read Last Updated : May 03 2021 | 3:49 PM IST

A Maharashtra minister on Monday

said Serum Institute of India's CEO Adar Poonawalla should lodge a police complaint in connection with the alleged threats that he has received, and assured the state government will conduct an in-depth probe into it.

Poonawalla, who has been in the UK on extended stay to evade alleged threats in India over the ever-increasing demand for COVID-19 vaccines, has said he will return in a few days.

In a recent interview to 'The Times', Poonawalla alleged that he had been receiving threats in India and that he and his family left the country for London after unprecedented "pressure and aggression" over the demand of COVID-19 vaccines.

The Pune-based Serum Institute of India (SII) is producing 'Covishield' - the Oxford/AstraZeneca's COVID-19 vaccine.

"Poonawalla should lodge a complaint giving details of threat and the phone number from where he got the call. We will conduct an in-depth probe into it," Minister of State Home Shamburaje Desai told reporters.

Meanwhile, Maharashtra Congress president Nana Patole urged Poonawalla to return to India and assured that his party will take the responsibility of his security.

"People's lives are important and the vaccine productionshould take place in India only. The Centre has already given him 'Y' category security. More (security) would be given if necessary," he said.

The Congress will also take the responsibility of protecting him, said Patole, whose party shares power in Maharashtra with the Shiv Sena and NCP.

"No one will touch him. He should return and work on vaccine production," the Congress leader said.

However, NCP leader and state Minority Affairs Minister Nawab Malik claimed Poonawalla was responsible for the present situation he is in and that no one was defaming him.

"First, he announces Rs 150 price (per dose of Covishield vaccine) for the central government,Rs 400 for states and Rs 700 for private hospitals. Later, through a tweet he informed that he was reducing the price for states from Rs 400 to Rs 300," Malik said.

This has created suspicion and there are lot of questions in the minds of the people, the minister said.

Earlier, NCP leader and Maharashtra Housing Minister Jitendra Awhad said the country needs to know the truth behind the alleged threats to Poonawalla.

(Only the headline and picture of this report may have been reworked by the Business Standard staff; the rest of the content is auto-generated from a syndicated feed.)

*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

More From This Section

Topics :Serum Institute of IndiaMaharashtraCoronavirus Vaccine

First Published: May 03 2021 | 3:40 PM IST

Next Story